These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31471732)

  • 21. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
    Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.
    Zhang ZQ; Meng H; Wang N; Liang LN; Liu LN; Lu SM; Luan Y
    Diagn Pathol; 2014 Jul; 9():135. PubMed ID: 24993656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
    Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
    Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
    Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
    Pathol Res Pract; 2024 Jun; 258():155327. PubMed ID: 38692084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.
    Khairy A; Hamza I; Shaker O; Yosry A
    Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of circulating microRNA-21 and microRNA-215 in the diagnosis of hepatitis C related hepatocellular carcinoma.
    Abdelkhalek ZS; Abdalla MS; Fathy MM; Elbaz TM; Abdelaziz AO; Nabeel MM; Shousha HI; Kamel AH; Kamel MH
    J Infect Dev Ctries; 2021 Jul; 15(7):997-1003. PubMed ID: 34343125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
    Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.
    Yamashita S; Kato A; Akatsuka T; Sawada T; Asai T; Koyama N; Okita K
    World J Gastroenterol; 2020 Apr; 26(13):1463-1473. PubMed ID: 32308347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
    Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J
    J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.